Quality improvement in molecular pathology laboratories: providing the means for process management and standardization of pre-analytical handling of small biopsies. KU Leuven
The introduction of biomarker testing in cancer diagnosis has enabled a more personalized approach to the clinical management of these diseases. However, these tests require a closer monitoring of the total test process in order to avoid non-conformities. The pre-analytical phase in specific brings along challenges that can influence the analytical outcomes. Particularly with the use of high-throughput methods for molecular biomarker ...